Thomas Parsons

Dr. Thomas Parsons

University of North Texas
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in Journal of Behavior Therapy and Experimental Psychiatry
Verified
Journal Article
Closed access
Thomas ParsonsThomas Parsons
Thomas Parsons
ARAlbert A. Rizzo
Albert A. Rizzo

11 December 2015 in Frontiers in Human Neuroscience
Verified
Journal Article
Open access
PDF file
Thomas ParsonsThomas Parsons
Thomas Parsons
An essential tension can be found between researchers interested in ecological validity and those concerned with maintaining experimental control. Research in the human neurosciences often involves the use of simple and static stimuli lacking many of the potentially important aspects of real world activities and interactions. While this research is valuable, there is a growing interest in the human neurosciences to use cues about target states in the real world via multimodal scenarios that involve visual, semantic, and prosodic information. These scenarios should include dynamic stimuli presented concurrently or serially in a manner that allows researchers to assess the integrative processes carried out by perceivers over time. Furthermore, there is growing interest in contextually embedded stimuli that can constrain participant interpretations of cues about a target’s internal states. Virtual reality environments proffer assessment paradigms that combine the experimental control of laboratory measures with emotionally engaging background narratives to enhance affective experience and social interactions. The present review highlights the potential of virtual reality environments for enhanced ecological validity in the clinical, affective, and social neurosciences.

1 September 2007 in AIDS
Verified
Journal Article
Closed access
KRKevin R Robertson
Kevin R Robertson
MSMarlene Smurzynski
Marlene Smurzynski
Thomas ParsonsThomas Parsons
Thomas Parsons
KWKunling Wu
Kunling Wu
RBRonald J Bosch
Ronald J Bosch
RERon J Ellis
Ron J Ellis
Objectives: HAART suppresses HIV viral replication and restores immune function. The effects of HAART on neurological disease are less well understood. The aim of this study was to assess the prevalence and incidence of neurocognitive impairment in individuals who initiated HAART as part of an AIDS clinical trial. Design: A prospective cohort study of HIV-positive patients enrolled in randomized antiretroviral trials, the AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) study. Methods: We examined the association between baseline and demographic characteristics and neurocognitive impairment among 1160 subjects enrolled in the ALLRT study. Results: A history of immunosuppression (nadir CD4 cell count < 200 cells/μl) was associated with an increase in prevalent neurocognitive impairment. There were no significant virological and immunological predictors of incident neurocognitive impairment. Current immune status (low CD4 cell count) was associated with sustained prevalent impairment. Conclusion: The association of previous advanced immunosuppression with prevalent and sustained impairment suggests that there is a non-reversible component of neural injury that tracks with a history of disease progression. The association of sustained impairment with worse current immune status (low CD4 cell count) suggests that restoring immunocompetence increases the likelihood of neurocognitive recovery. Finally, the lack of association between incident neurocognitive impairment and virological and immunological indicators implies that neural injury continues in some patients regardless of the success of antiretroviral therapy on these laboratory measures.

1 July 2006 in The Lancet Neurology
Verified
Journal Article
Closed access
Thomas ParsonsThomas Parsons
Thomas Parsons
SRSteven A Rogers
Steven A Rogers
ABAlyssa J Braaten
Alyssa J Braaten
SWSteven Paul Woods
Steven Paul Woods
ATAlexander I Tröster
Alexander I Tröster

1 January 2004 in Neuropsychologia
Verified
Journal Article
Closed access
Thomas ParsonsThomas Parsons
Thomas Parsons
PLPeter Larson
Peter Larson
KKKris Kratz
Kris Kratz
MTMarcus Thiebaux
Marcus Thiebaux
BBBrendon Bluestein
Brendon Bluestein
ARAlbert A Rizzo
Albert A Rizzo

11 June 2007 in Child Neuropsychology
Verified
Journal Article
Closed access
Thomas ParsonsThomas Parsons
Thomas Parsons
TBTodd Bowerly
Todd Bowerly
JBJ. Galen Buckwalter
J. Galen Buckwalter
ARAlbert A. Rizzo
Albert A. Rizzo
In this initial pilot study, a controlled clinical comparison was made of attention perforance in children with attention deficit-hyperactivity disorder (ADHD) in a virtual reality (VR) classroom. Ten boys diagnosed with ADHD and ten normal control boys participated in the study. Groups did not significantly differ in mean age, grade level, ethnicity, or handedness. No participants reported simulator sickness following VR exposure. Children with ADHD exhibited more omission errors, commission errors, and overall body movement than normal control children in the VR classroom. Children with ADHD were more impacted by distraction in the VR classroom. VR classroom measures were correlated with traditional ADHD assessment tools and the flatscreen CPT. Of note, the small sample size incorporated in each group and higher WISC-III scores of normal controls might have some bearing on the overall interpretation of results. These data suggested that the Virtual Classroom had good potential for controlled performance assessment within an ecologically valid environment and appeared to parse out significant effects due to the presence of distraction stimuli.